English | Español

Community
+ Community
Gabriella Ayres | Jan 21, 2016

NORD introduces Patient/Caregiver Speakers Bureau for rare diseases
+ Community
Carol Ostrow | Jan 20, 2016

Ex-smokers rally behind CDC ad campaign, quit-line
+ Technology/Innovation
Carol Ostrow | Jan 20, 2016

NIH-backed study reveals genetic links to age-related macular degeneration
+ Technology/Innovation
Jamie Barrand | Jan 20, 2016

Researchers discuss findings from pregnancy studies on lupus patients
+ Technology/Innovation
Carol Ostrow | Jan 20, 2016

Synthetic Biologics announces encouraging clinical trial results for IBS patients
+ Technology/Innovation
Gabriella Ayres | Jan 19, 2016

EU approves first Enbrel-referencing biosimilar treatment
+ Technology/Innovation
Kim Sunderland | Jan 18, 2016

Johns Hopkins public health expert encourages inclusion of patient preferences in medicinal development
+ Regulatory
Katelyn Kivel | Jan 18, 2016

NAMI expresses concerns surrounding national mental health situation

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes